# A cross-talk between Hepatitis B virus and host mRNAs confers viral adaptation to liver

**Authors:** Jun Hu, Yaxing Xu, Changfei Li, Junli Hao, Shanxin Peng, Xiaoyu Chu, Dake Zhang, Dongping Xu, Songdong Meng

PMC · DOI: 10.1038/srep10572 · Scientific Reports · 2015-07-17

## TL;DR

This study shows how Hepatitis B virus interacts with a liver-specific microRNA to enhance its replication and adapt to the host environment.

## Contribution

The study reveals a novel mechanism where HBV uses miR-122 response elements to manipulate host gene expression and promote viral replication.

## Key findings

- HBV uses miR-122 response elements to increase its expression and replication in liver cells.
- HBV mRNA can down-regulate miR-122 and alter host gene expression, aiding viral replication.
- Mutations in miR-122 response elements correlate with higher viral loads and disease progression in patients.

## Abstract

Hepatitis B virus (HBV) chronically infects approximately 350 million people worldwide. The replication of HBV which genome is only 3.2 kb long relies heavily on host factors. Previous studies demonstrated that a highly expressed liver-specific microRNA (miRNA) miR-122 suppresses HBV expression and replication in multiple ways. In this study, we found that the miR-122 response elements in viral genome facilitate HBV expression and replication in miR-122 highly-expressed hepatocytes. Moreover, mutations in miR-122 response elements are correlated with viral loads and disease progression in HBV-infected patients. We next found that HBV mRNA with miR-122 response elements alone could lead to altered expression of multiple host genes by whole genome expression analysis. HBV mRNA-mediated miR-122 down-regulation plays a major role in HBV mRNA-induced differential gene expression. HBV mRNA could enhance viral replication via miR-122 degradation and the up-regulation of its target cyclin G1. Our study thereby reveals that under the unique condition of high abundance of miR-122 and viral mRNAs and much lower level of miR-122 target in HBV infection, HBV may have evolved to employ the miRNA-mediated virus and host mRNAs network for optimal fitness within hepatocytes.

## Linked entities

- **Genes:** MIR122 (microRNA 122) [NCBI Gene 406906], CCNG1 (cyclin G1) [NCBI Gene 595110]

## Full-text entities

- **Genes:** MIR152 (microRNA 152) [NCBI Gene 406943] {aka MIRN152, mir-152}, TREM1 (triggering receptor expressed on myeloid cells 1) [NCBI Gene 54210] {aka CD354, TREM-1}, AGO2 (argonaute RISC catalytic component 2) [NCBI Gene 27161] {aka CASC7, EIF2C2, LESKRES, LINC00980, PPD, Q10}, BCL2L2 (BCL2 like 2) [NCBI Gene 599] {aka BCL-W, BCL2-L-2, BCLW, PPP1R51}, DROSHA (drosha ribonuclease III) [NCBI Gene 29102] {aka ETOHI2, HSA242976, RANSE3L, RN3, RNASE3L, RNASEN}, HSP90B1 (heat shock protein 90 beta family member 1) [NCBI Gene 7184] {aka ECGP, GP96, GRP94, HEL-S-125m, HEL35, TRA1}, Mir122 (microRNA 122) [NCBI Gene 387231] {aka Mir122a, Mir122b, Mirn122a, Mirn122b, mir-122, mmu-mir-122}, PTTG1 (PTTG1 regulator of sister chromatid separation, securin) [NCBI Gene 9232] {aka EAP1, ECRAR, HPTTG, PTTG, TUTR1}, MIR17 (microRNA 17) [NCBI Gene 406952] {aka MIR17-5p, MIR91, MIRN17, MIRN91, hsa-mir-17, miR-17}, Ccng1 (cyclin G1) [NCBI Gene 12450], TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, MIR192 (microRNA 192) [NCBI Gene 406967] {aka MIRN192, miR-192, miRNA192}, HBE1 (hemoglobin subunit epsilon 1) [NCBI Gene 3046] {aka HBE}, PRKRA (protein activator of interferon induced protein kinase EIF2AK2) [NCBI Gene 8575] {aka DYT16, HSD14, PACT, RAX}, MIR122 (microRNA 122) [NCBI Gene 406906] {aka MIR122A, MIRN122, MIRN122A, hsa-mir-122, miRNA122, miRNA122A}, NR1I2 (nuclear receptor subfamily 1 group I member 2) [NCBI Gene 8856] {aka BXR, ONR1, PAR, PAR1, PAR2, PARq}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}, PTTG1IP (PTTG1 interacting protein) [NCBI Gene 754] {aka C21orf1, C21orf3, PBF, PTTG1IP1}, MIR642A (microRNA 642a) [NCBI Gene 693227] {aka MIR642, MIRN642, hsa-mir-642, hsa-mir-642a, mir-642a}, RXRA (retinoid X receptor alpha) [NCBI Gene 6256] {aka NR2B1, RXR-alpha, RXRalpha}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, MIR33A (microRNA 33a) [NCBI Gene 407039] {aka MIR33, MIRN33, MIRN33A, hsa-mir-33, hsa-mir-33a, miR-33}, BCHE (butyrylcholinesterase) [NCBI Gene 590] {aka BCHED, CHE1, CHE2, E1}, MIR22 (microRNA 22) [NCBI Gene 407004] {aka MIRN22, hsa-mir-22, miR-22}, PreS1 [NCBI Gene 944569], MIR20A (microRNA 20a) [NCBI Gene 406982] {aka C13orf25, MIR20, MIRH1, MIRHG1, MIRN20, MIRN20A}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, GIT1 (GIT ArfGAP 1) [NCBI Gene 28964] {aka p95-APP1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, DICER1 (dicer 1, ribonuclease III) [NCBI Gene 23405] {aka DCR1, Dicer, Dicer1e, GLOW, HERNA, K12H4.8-LIKE}, NT5C3A (5'-nucleotidase, cytosolic IIIA) [NCBI Gene 51251] {aka CNSHA8, NT5C3, P5'N-1, P5N-1, PN-I, POMP}, CCNG1 (cyclin G1) [NCBI Gene 900] {aka CCNG}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}
- **Diseases:** infection (MESH:D007239), HBV infection (MESH:D006509), HCC (MESH:D006528), hepatic cholestasis (MESH:D002779), Liver Failure (MESH:D017093), chronic hepatitis B (MESH:D019694), autoimmune diseases (MESH:D001327), Infectious Diseases (MESH:D003141), inflammation (MESH:D007249), jaundice (MESH:D007565), hepatic insult (MESH:D056486), hepatic fibrosis (MESH:D008103), viral infection (MESH:D014777), cancer (MESH:D009369), liver diseases (MESH:D008107), ACLF (MESH:D065290), CHB-S (MESH:D018455), CHB-M (MESH:C566367),  (MESH:D018450)
- **Species:** Hepatitis B virus (no rank) [taxon 10407], Mus musculus (house mouse, species) [taxon 10090], Human betaherpesvirus 5 (no rank) [taxon 10359], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** L60V
- **Cell lines:** Huh-7 — Homo sapiens (Human), Adult hepatocellular carcinoma, Cancer cell line (CVCL_0336), 293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), BALB/c — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0184), pRL- — Mus musculus (Mouse), Transformed cell line (CVCL_U368), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), HepG2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4505342/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4505342/full.md

## References

34 references — full list in the complete paper: https://tomesphere.com/paper/PMC4505342/full.md

---
Source: https://tomesphere.com/paper/PMC4505342